Clinical Trial

Metagenomic Analysis of Bacterial Microbiota in Breast Milk

Study acronym: MIC-LAMA2
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-09-07; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-12
Status change: Recruiting → Not Yet Recruiting 2025-03-12
Status change: Not Yet Recruiting → Recruiting 2024-11-22
Trial Details
NCT Number NCT06037421
Lead Sponsor Centre Hospitalier Sud Francilien
Conditions Bacteria in Breast Milk
Enrollment 120 participants
Start Date 2025-09-08
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16